Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in Interest ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Nuvation Bio (NUVB) Change in Account Payables (2023 - 2025)

Historic Change in Account Payables for Nuvation Bio (NUVB) over the last 3 years, with Q3 2025 value amounting to -$7.1 million.

  • Nuvation Bio's Change in Account Payables fell 19846.56% to -$7.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.0 million, marking a year-over-year decrease of 2928.33%. This contributed to the annual value of -$1.7 million for FY2024, which is 246285.71% down from last year.
  • Nuvation Bio's Change in Account Payables amounted to -$7.1 million in Q3 2025, which was down 19846.56% from $11.9 million recorded in Q2 2025.
  • In the past 5 years, Nuvation Bio's Change in Account Payables registered a high of $11.9 million during Q2 2025, and its lowest value of -$7.1 million during Q3 2025.
  • Its 3-year average for Change in Account Payables is $675272.7, with a median of -$164000.0 in 2023.
  • Data for Nuvation Bio's Change in Account Payables shows a peak YoY increase of 361421.57% (in 2024) and a maximum YoY decrease of 357804.88% (in 2024) over the last 5 years.
  • Over the past 3 years, Nuvation Bio's Change in Account Payables (Quarter) stood at -$164000.0 in 2023, then plummeted by 3578.05% to -$6.0 million in 2024, then decreased by 17.03% to -$7.1 million in 2025.
  • Its last three reported values are -$7.1 million in Q3 2025, $11.9 million for Q2 2025, and $4.2 million during Q1 2025.